Category: Melanoma Group

Melanoma Group / News

EORTC study published in NEJM shows prolonged survival in stage III melanoma

8 Oct
Melanoma Group / News

FDA Approves Adjuvant Yervoy in Melanoma based on results of EORTC trial 18071

13 Nov
Melanoma Group / News

Will adjuvant pembrolizumab improve recurrence-free survival for patients with high-risk Stage III melanoma?

14 Sep
Melanoma Group / News

EORTC opens prospective registry for patients with Melanoma

12 Jun
Melanoma Group / News

Adjuvant Ipilimumab significantly effects recurrence-free survival in patients after resection of high risk lymph node positive melanoma

20 Apr
Melanoma Group / News / Uncategorized

Pr Alexander Eggermont presented the initial efficacy and safety results from EORTC trial 18071 at ASCO 2014 in Chicago

11 Jun
Melanoma Group / News / Uncategorized

Vaccination with GM2-KLH-QS21 does not improve outcome stage II melanomas patients in EORTC study

13 Sep
Melanoma Group / News / Uncategorized

EORTC Melanoma Group study selects AS15 adjuvant for active immunization with MAGE A3 protein for treatment of metastatic melanoma

29 May
Melanoma Group / News / Uncategorized

Gender plays a role in progression-free and disease-specific survival according to five EORTC studies in stage III-IV melanoma patients

23 May
Melanoma Group / News / Uncategorized

EORTC Melanoma Group investigating use of PEG-IFN- α-2b for patients with stage II ulcerated primary cutaneous melanoma

16 Jan
1 2 3 … 31